LifeMD Q2 2024 Adj. EPS $0.06 Beats $(0.12) Estimate, Sales $50.662M Beat $48.251M Estimate
Portfolio Pulse from Benzinga Newsdesk
LifeMD (NASDAQ:LFMD) reported Q2 2024 earnings of $0.06 per share, significantly beating the analyst consensus estimate of $(0.12). The company also reported quarterly sales of $50.662 million, surpassing the $48.251 million estimate and marking a 40.94% increase from the same period last year.
August 07, 2024 | 9:41 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
LifeMD reported Q2 2024 earnings of $0.06 per share, beating the $(0.12) estimate by 150%. Sales of $50.662 million also surpassed the $48.251 million estimate, showing a 40.94% YoY increase.
LifeMD's strong earnings and revenue performance, significantly beating analyst estimates, is likely to positively impact the stock price in the short term. The 40.94% YoY increase in sales further underscores the company's growth momentum.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100